Axitinib and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Axitinib (axitinib), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Miralax, and have Renal cell carcinoma.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Axitinib. It is created by eHealthMe based on reports of 3,177 people who have side effects when taking Axitinib from the FDA, and is updated regularly.

What is Axitinib?

Axitinib has active ingredients of axitinib. eHealthMe is studying from 3,179 Axitinib users. Check the latest studies of Axitinib.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,303 drugs and 1,658 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

On Jul, 26, 2026

3,177 people reported to have side effects when taking Axitinib.
Among them, 82 people (2.58%) have Dyspnea exacerbated.

Could Axitinib cause Dyspnea exacerbated?

Among these 82 people:

How long have people been on Axitinib when they have Dyspnea exacerbated? *

What is the gender of people who have Dyspnea exacerbated when taking Axitinib? *

female: 25 %
male: 75 %

What is the age of people who have Dyspnea exacerbated when taking Axitinib? *

What are other drugs people take besides Axitinib? *

What are other side effects people have besides Dyspnea exacerbated? *

Nausea (feeling of having an urge to vomit): 15 people, 18.29%
Fatigue (feeling of tiredness): 14 people, 17.07%
Diarrhea: 13 people, 15.85%
High Blood Pressure: 13 people, 15.85%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 12 people, 14.63%
Chest Pain: 10 people, 12.20%
Pleural Effusion (water on the lungs): 9 people, 10.98%
Pain: 8 people, 9.76%
Malignant Neoplasm Progression (cancer tumour came back): 7 people, 8.54%
Drowsiness: 7 people, 8.54%

What are the existing conditions these people have? *

Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 24 people, 29.27%
Renal Cell Carcinoma (a kidney cancer): 24 people, 29.27%
Nausea (feeling of having an urge to vomit): 10 people, 12.20%
High Blood Pressure: 10 people, 12.20%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 9 people, 10.98%
Pain: 8 people, 9.76%
Renal Cancer Metastatic (cancer of kidney spreads to other part): 7 people, 8.54%
Stress And Anxiety: 6 people, 7.32%
Insomnia (sleeplessness): 5 people, 6.10%
High Blood Cholesterol: 3 people, 3.66%

* Approximation only. Some reports may have incomplete information.

Do you take Axitinib and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Axitinib:

Axitinib (3,179 reports)

Browse all side effects of Axitinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (3,303 drugs)

Browse all the conditions that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (1,658 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on axitinib (the active ingredients of Axitinib) and Axitinib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.